Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper platform for bacterial and fungal identification and establish, DNA test strips, and; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was founded in 1960 and is headquartered in Billerica, Massachusetts.

Bruker Corporation

The latest update is out from Bruker ( ($BRKR) ). On August 14, 2026, Bruker Corporation’s Board of Directors declared a quarterly cash dividend of...

Bruker Board Declares Quarterly Cash Dividend for Shareholders

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bruker (BRKR) and Arvinas Holding Company (ARVN) wit...

Analysts Are Bullish on These Healthcare Stocks: Bruker (BRKR), Arvinas Holding Company (ARVN)

Wells Fargo analyst maintained a Buy rating on Bruker today and set a price target of $55.00. Bruker has an analyst consensus of Moderate Buy, with...

Bruker (BRKR) Receives a Buy from Wells Fargo

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Spyre Therapeutics (SYRE), Ultragenyx Pharmaceutic...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Spyre Therapeutics (SYRE), Ultragenyx Pharmaceutical (RARE) and Bruker (BRKR)

Bruker Corporation (($BRKR)) has held its Q2 earnings call. Read on for the main highlights of the call. Bruker Corporation’s latest earnings call ...

Bruker Corporation Earnings Call Highlights Margin Strength

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MannKind (MNKD), Bruker (BRKR) and BrightSpring He...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BRKR	$57.70	0.00%	1.75M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BRKR	$57.70	0%	1.75M
3
4
5
6

BRKR

Get Bruker Corporation Data in Excel

Get Bruker Corporation Data in Excel